1. Home
  2. TECX vs BOC Comparison

TECX vs BOC Comparison

Compare TECX & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • BOC
  • Stock Information
  • Founded
  • TECX 2019
  • BOC 2009
  • Country
  • TECX United States
  • BOC United States
  • Employees
  • TECX N/A
  • BOC N/A
  • Industry
  • TECX
  • BOC
  • Sector
  • TECX
  • BOC
  • Exchange
  • TECX Nasdaq
  • BOC Nasdaq
  • Market Cap
  • TECX 387.1M
  • BOC 413.9M
  • IPO Year
  • TECX 2018
  • BOC 2017
  • Fundamental
  • Price
  • TECX $18.92
  • BOC $12.41
  • Analyst Decision
  • TECX Buy
  • BOC Strong Buy
  • Analyst Count
  • TECX 6
  • BOC 1
  • Target Price
  • TECX $79.17
  • BOC $25.00
  • AVG Volume (30 Days)
  • TECX 682.4K
  • BOC 141.1K
  • Earning Date
  • TECX 11-06-2025
  • BOC 11-13-2025
  • Dividend Yield
  • TECX N/A
  • BOC N/A
  • EPS Growth
  • TECX N/A
  • BOC N/A
  • EPS
  • TECX N/A
  • BOC 0.02
  • Revenue
  • TECX N/A
  • BOC $111,568,551.00
  • Revenue This Year
  • TECX N/A
  • BOC $7.79
  • Revenue Next Year
  • TECX N/A
  • BOC $3.80
  • P/E Ratio
  • TECX N/A
  • BOC $600.33
  • Revenue Growth
  • TECX N/A
  • BOC 9.53
  • 52 Week Low
  • TECX $13.70
  • BOC $12.24
  • 52 Week High
  • TECX $61.07
  • BOC $16.10
  • Technical
  • Relative Strength Index (RSI)
  • TECX 55.49
  • BOC 33.22
  • Support Level
  • TECX $18.49
  • BOC $12.35
  • Resistance Level
  • TECX $20.39
  • BOC $12.65
  • Average True Range (ATR)
  • TECX 2.22
  • BOC 0.30
  • MACD
  • TECX 0.14
  • BOC -0.08
  • Stochastic Oscillator
  • TECX 31.09
  • BOC 11.24

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: